As of November 7, 2026, NovaBridge Biosciences is a publicly traded company (Nasdaq: NBP). The largest holder reporting an active stake on Schedule 13D is Everest Medicines Limited, at 16.1%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D, August 5, 2025).
Is this your company?
About to sign with, pay or invest in NovaBridge Biosciences? See the free Snapshot first.
Free to see. No signup.
Is NovaBridge Biosciences a real, registered company?
- NovaBridge Biosciences files with the SEC under CIK 1778016 (its SEC filings).
- Its shares are listed under the ticker NBP on Nasdaq (SEC company record).
- Incorporated in E9; business address in Rockville, Maryland, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under NovaBridge Biosciences in our court records and SEC 8-K records (as of 2026-11-07).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names CBC Investment I-Mab Limited (filed 2026-02-03).
Who are NovaBridge Biosciences' owners and officers?
NovaBridge Biosciences: business address in Rockville, Maryland; industry Pharmaceutical Preparations (Schedule 13D/A, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-11-05 | Hhlr Advisors, LTD. | 4.9% |
| Schedule 13D/A, 2026-02-03 | Cbc Investment I-Mab Limited | 11.5% |
| Schedule 13D/A, 2025-08-07 | Cbc Investment I-Mab Limited | 10.4% |
| Schedule 13D, 2025-08-05 | Everest Medicines Limited | 16.1% |
Questions about who owns NovaBridge Biosciences
Who owns NovaBridge Biosciences?
On this page, 2 holders' latest ownership filings report 5% or more of NovaBridge Biosciences: Everest Medicines Limited (16.1%, Schedule 13D, filed 2025-08-05) and Cbc Investment I-Mab Limited (11.5%, Schedule 13D/A, filed 2026-02-03).
Who are the largest shareholders of NovaBridge Biosciences?
By the share each holder's latest filing reports, the largest holders of NovaBridge Biosciences on this page are Everest Medicines Limited (16.1%) and Cbc Investment I-Mab Limited (11.5%).
When did Everest Medicines Limited buy into NovaBridge Biosciences?
The filings give report dates, not purchase dates. The earliest filing from Everest Medicines Limited on this page is the Schedule 13D, filed 2025-08-05, reporting 16.1%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on NovaBridge Biosciences?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on NovaBridge Biosciences: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on NovaBridge Biosciences covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own NovaBridge Biosciences shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 13,271 shares (0.01% of shares outstanding) (Form 4, 2026-10-19).
Shares outstanding: 265,377,891 as of 2025-12-31, from the company's latest SEC cover page.
How much has NovaBridge Biosciences raised?
No fundraising or offering filing from NovaBridge Biosciences is on file with us.
Keep reading
More on NovaBridge Biosciences and the records around it.
NovaBridge Biosciences elsewhere on the record
- 5%+ stake filings Nov 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/novabridge-biosciences